Modeling the transition of lung cancer from early to advanced stage

Cancer Causes and Control

Volumn 20, Issue 9, 2009, Pages 1559-1569

  Pashkevich, Maksim A ^a   Sigal, Bronislava M ^a   Plevritis, Sylvia K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lung cancer; Mayo Lung Project; Metastatic progression; Natural history model; Screening

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER SCREENING; CANCER SIZE; CANCER STAGING; CONTROLLED STUDY; EARLY CANCER; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MAXIMUM LIKELIHOOD METHOD; PRIORITY JOURNAL; PROBABILITY; STOCHASTIC MODEL; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, THEORETICAL; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 70350599173     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-009-9401-4     Document Type: Article

References (35)

1. A Jemal T Murray E Ward A Samuels RC Tiwari A Ghafoor EJ Feuer MJ Thun 2005 Cancer statistics, 2005 CA Cancer J Clin 55 10 30 10.3322/canjclin.55.1.10 10.3322/canjclin.55.1.10 15661684
2. DM Eddy 1989 Screening for lung cancer Ann Intern Med 111 232 237 1:STN:280:DyaL1MzitFWqsw%3D%3D 2665590
3. PM Marcus EJ Bergstralh MH Zweig A Harris KP Offord RS Fontana 2006 Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis J Natl Cancer Inst 98 748 756 16757699
4. PM Marcus EJ Bergstralh RM Fagerstrom DE Williams R Fontana WF Taylor PC Prorok 2000 Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up J Natl Cancer Inst 92 1308 1316 10.1093/jnci/92.16.1308 10.1093/jnci/92.16.1308 1:STN:280:DC%2BD3cvjvVCluw%3D%3D 10944552
5. CI Henschke DI McCauley DF Yankelevitz DP Naidich G McGuinness OS Miettinen DM Libby MW Pasmantier J Koizumi NK Altorki JP Smith 1999 Early Lung Cancer Action Project: overall design and findings from baseline screening Lancet 354 99 105 10.1016/S0140-6736(99)06093-6 10.1016/S0140-6736(99)06093-6 1:STN:280:DyaK1MzjsV2luw%3D%3D 10408484 (Pubitemid 29313143)
6. WC Black 2000 Overdiagnosis: an underrecognized cause of confusion and harm in cancer screening J Natl Cancer Inst 92 1280 1282 10.1093/jnci/92.16.1280 10.1093/jnci/92.16.1280 1:STN:280:DC%2BD3cvjvVClsg%3D%3D 10944539
7. WC Black JA Baron 2007 CT screening for lung cancer: spiraling into confusion? J Am Med Assoc 297 995 997 10.1001/jama.297.9.995 10.1001/jama.297.9.995 1:CAS:528:DC%2BD2sXisFKlsr8%3D (Pubitemid 46376753)
8. National Cancer Institute Web site (2008) National lung screening trial. http://www.cancer.gov/nlst. Accessed 4 September 4 2008
9. CI Henschke DF Yankelevitz DM Libby MW Pasmantier JP Smith OS Miettinen 2006 Survival of patients with stage I lung cancer detected on CT screening N Engl J Med 355 1763 1771 10.1056/NEJMoa060476 10.1056/NEJMoa060476 17065637 (Pubitemid 44631359)
10. PB Bach JR Jett U Pastorino MS Tockman SJ Swensen CB Begg 2007 Computed tomography screening and lung cancer outcomes J Am Med Assoc 297 953 961 10.1001/jama.297.9.953 10.1001/jama.297.9.953 1:CAS:528:DC%2BD2sXisFKns7k%3D (Pubitemid 46376749)
11. M Shwartz 1978 A mathematical model used to analyze breast cancer screening strategies Oper Res 26 955 973 10.1287/opre.26.6.937 10.1287/opre.26.6.937
12. M Shwartz 1981 Validation and use of a mathematical model to estimate the benefits of screening younger women for breast cancer Cancer Detect Prev 4 595 601 1:STN:280:DyaL3s7lsFGisw%3D%3D 7349826
13. Plevritis SK, Sigal BM, Pashkevich MA (2007) Mortality reduction due to x-ray screening: stochastic simulation of Mayo Lung Project. Manuscript in preparation
14. SK Plevritis A Kurian BM Sigal B Daniel D Ikeda F Stockdale AM Garber 2006 Cost-effectiveness of screening for breast cancer with magnetic resonance imaging in BRCA1/2 mutation carriers JAMA 295 2374 2384 10.1001/jama.295.20.2374 10.1001/jama.295.20.2374 1:CAS:528:DC%2BD28Xlt1WksL8%3D 16720823 (Pubitemid 43788105)
15. SK Plevritis BM Sigal P Salzman P Glynn J Rosenberg 2006 A stochastic simulation model of US breast cancer mortality trends from 1975 to 2000 J Natl Cancer Inst Monogr 36 86 95 17032898
16. DA Berry KA Cronin SK Plevritis DG Fryback LC Clark M Zelen JS Mandelblatt AY Yakovlev JDF Habbema EJ Feuer 2005 Contributions of screening and adjuvant treatment to reduction in breast cancer mortality in the US from 1975 to 2000 N Engl J Med 353 1784 1792 10.1056/NEJMoa050518 10.1056/NEJMoa050518 1:CAS:528:DC%2BD2MXhtFKrtLbN 16251534 (Pubitemid 41549890)
17. S Koscielny M Tubiana MG Le AJ Valleron H Mouriesse G Contesso D Sarrazin 1984 Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination Br J Cancer 49 709 715 1:STN:280:DyaL2c3jtF2jtw%3D%3D 6733019
18. EN Atkinson BW Brown JR Thompson 1983 On estimating the growth function of tumours Math Biosci 67 145 166 10.1016/0025-5564(83)90097-4 10.1016/0025-5564(83)90097-4
19. R Bartoszynski L Edler L Hanin A Kopp-Schneider L Pavlova A Tsodikov A Zorin AY Yakovlev 2001 Modeling cancer detection: tumour size as a source of information on unobservable stages of carcinogenesis Math Biosci 171 113 142 10.1016/S0025-5564(01)00058-X 10.1016/S0025-5564(01)00058-X 1:STN:280: DC%2BD3MzntlGlsQ%3D%3D 11395047 (Pubitemid 32565742)
20. SW Duffy HH Chen L Tabar NE Day 1995 Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase Stat Med 14 1531 1543 10.1002/sim. 4780141404 10.1002/sim.4780141404 1:STN:280:DyaK28%2FgtVynsQ%3D%3D 7481190
21. SW Duffy NE Day L Tabar HH Chen TC Smith 1997 Markov models of breast tumour progression: some age-specific results J Natl Cancer Inst Monogr 22 93 97 9709283
22. D Ghosh 2006 Modelling tumour biology-progression relationships in screening trials Stat Med 25 1872 1884 10.1002/sim.2363 10.1002/sim.2363 16220483 (Pubitemid 43826840)
23. SK Plevritis P Salzman BM Sigal PW Glynn 2007 A natural history model of stage progression applied to breast cancer Stat Med 26 581 595 10.1002/sim.2550 10.1002/sim.2550 16598706 (Pubitemid 46139540)
24. L Hanin J Rose M Zaider 2006 A stochastic model for the sizes of detectable metastases J Theor Biol 243 407 417 10.1016/j.jtbi.2006.07.005 10.1016/j.jtbi.2006.07.005 16930629 (Pubitemid 44647327)
25. M Kimmel BJ Flehinger 1991 Nonparametric estimation of the size-metastasis relationship in solid cancers Biometrics 47 987 1004 10.2307/2532654 10.2307/2532654 1:STN:280:DyaK38%2FnsFyktw%3D%3D 1742451
26. JL Xu PC Prorok 1997 Nonparametric estimation of solid cancer size at metastasis and probability of presenting with metastasis at detection Biometrics 53 579 591 10.2307/2533959 10.2307/2533959 1:STN:280:DyaK2szjsFOrtQ%3D%3D 9192453 (Pubitemid 27262220)
27. JL Xu PC Prorok 1998 Estimating a distribution function of the tumor size at metastasis Biometrics 54 859 864 10.2307/2533840 10.2307/2533840 1:STN:280:DyaK1cvit1KgsQ%3D%3D 9750239 (Pubitemid 28429281)
28. Bartoszynski R (1987) A modeling approach to metastatic progression of cancer. In: Thompson JR, Brown PW (eds) Cancer modeling. Marcel Dekker, New York
29. VP Collins RK Loeffler H Tivey 1956 Observations on growth rates of human tumors Am J Roentgenol Radium Ther Nucl Med 76 988 1000 1:STN:280: DyaG2s%2FgvVOktQ%3D%3D 13362715
30. DM Geddes 1979 The natural history of lung cancer: a review based on rates of tumour growth Br J Dis Chest 73 1 17 1:STN:280:DyaE1M7ms1Wmsw%3D%3D 435370
31. JA Sherratt MAJ Chaplain 2001 A new mathematical model for avascular tumour growth J Math Biol 43 291 312 10.1007/s002850100088 10.1007/s002850100088 1:STN:280:DC%2BD38znsFCmtg%3D%3D 12120870
32. Johnson NL, Kotz S, Balkrishan N (1994) Continuous univariate distributions. Wiley, New York
33. RS Fontana DR Sanderson LB Woolner WF Taylor WE Miller JR Muhm PE Bernatz WS Payne PC Pairolero EJ Bergstralh 1991 Screening for lung cancer. A critique of the Mayo Lung Project Cancer 67 1155 1164 10.1002/1097-0142(19910215)67: 4+<1155::AID-CNCR2820671509>3.0.CO;2-0 10.1002/1097-0142(19910215)67: 4+<1155::AID-CNCR2820671509>3.0.CO;2-0 1:STN:280:DyaK3M7itFCjsQ%3D%3D 1991274
34. CI Henschke DF Yankelevitz WJ Kostis 2003 CT screening for lung cancer Semin Ultrasound CT MR 24 23 32 10.1016/S0887-2171(03)90022-9 10.1016/S0887-2171(03)90022-9 12708641 (Pubitemid 36397821)
35. American Joint Committee for Cancer Staging and End Results Reporting (1979) Task force on lung cancer: staging of lung cancer. American Joint Committee for Cancer Staging and End Results Reporting, Chicago